Stay updated on Complications of UTI in Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the Complications of UTI in Dapagliflozin Clinical Trial page.

Latest updates to the Complications of UTI in Dapagliflozin Clinical Trial page
- Check4 days agoChange DetectedThe NIH sitewide banner announcing website updates and terminology changes is no longer displayed.SummaryDifference1%

- Check11 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH notice says the agency is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and provides updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error, and its footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record details and navigation. This alters how users access the study information by restricting visibility.SummaryDifference15%

Stay in the know with updates to Complications of UTI in Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Complications of UTI in Dapagliflozin Clinical Trial page.